Organisation/Company CIC biomaGUNE Department Research in Biomaterials Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 15 Sep 2026 - 23:59 (UTC) Country Spain Type of Contract Temporary Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Nov 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Offer Description
The project, "Design and evaluation of repeat RNA-binding proteins for RNA-targeting therapies (RNATher)", aims to develop engineered RNA-binding proteins as a new platform for therapeutic modulation of disease-associated RNAs, with a particular focus on amyotrophic lateral sclerosis (ALS).
The PhD candidate will work on the design and engineering of programmable pentatricopeptide repeat (PPR) and Pumilio (PUF) proteins for sequence-specific RNA recognition and modulation.



Building on preliminary proof-of-concept results, the project will investigate the ability of engineered PPR proteins to correct STMN2 RNA misprocessing, a key molecular feature of ALS, in patient-derived cellular models and in vivo.
The project will also explore AI-guided protein engineering and protein language models to generate improved PPR and PUF variants with enhanced RNA-binding properties. In addition, these programmable RNA-binding scaffolds will be engineered to incorporate new therapeutic functionalities, including targeted RNA degradation and RNA editing.
The project is highly multidisciplinary and combines research and combines protein engineering, protein biochemistry and biophysics, molecular and cell biology, RNA biology, artificial intelligence-assisted protein design, and cellular and in vivo models of neurodegenerative disease.
The successful candidate will benefit from the complementary expertise of the two partic

📌 PhD Position in Protein Engineering and RNA-Targeting Therapies (España)
🏢 Cic Biomagune
📍 España